During the last session, NeuroOne Medical Technologies Corp (NASDAQ:NMTC)’s traded shares were 0.31 million, with the beta value of the company hitting 0.73. At the end of the trading day, the stock’s price was $0.68, reflecting an intraday loss of -2.69% or -$0.02. The 52-week high for the NMTC share is $2.00, that puts it down -194.12 from that peak though still a striking 11.76% gain since the share price plummeted to a 52-week low of $0.60. The company’s market capitalization is $20.98M, and the average intraday trading volume over the past 10 days was 0.19 million shares, and the average trade volume was 81.60K shares over the past three months.
NeuroOne Medical Technologies Corp (NASDAQ:NMTC) trade information
NeuroOne Medical Technologies Corp (NMTC) registered a -2.69% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.69% in intraday trading to $0.68, hitting a weekly high. The stock’s 5-day price performance is -4.22%, and it has moved by -31.89% in 30 days. Based on these gigs, the overall price performance for the year is -47.21%. The short interest in NeuroOne Medical Technologies Corp (NASDAQ:NMTC) is 0.12 million shares and it means that shorts have 2.07 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 23.08%.
NMTC Dividends
NeuroOne Medical Technologies Corp is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
NeuroOne Medical Technologies Corp (NASDAQ:NMTC)’s Major holders
NeuroOne Medical Technologies Corp insiders own 10.19% of total outstanding shares while institutional holders control 19.43%, with the float percentage being 21.64%. NANTAHALA CAPITAL MANAGEMENT, LLC is the largest shareholder of the company, while 23.0 institutions own stock in it. As of 2024-06-30, the company held over 0.95 million shares (or 3.6702% of all shares), a total value of $0.76 million in shares.
The next largest institutional holding, with 0.92 million shares, is of VANGUARD GROUP INC’s that is approximately 3.5489% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.74 million.
Also, the Mutual Funds coming in first place with the largest holdings of NeuroOne Medical Technologies Corp (NMTC) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 712.45 shares. This amounts to just over 5.96 percent of the company’s overall shares, with a $0.49 million market value. The same data shows that the other fund manager holds slightly less at 207.08, or about 1.73% of the stock, which is worth about $0.14 million.
